Product Information

TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.2814 per EA under NDC 71921010533. Its NADAC has been published 39 times since Feb 25, 2026.

FDA first approved this application on Mar 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET

Tenofovir Disoproxil Fumarate
$0.2814per EA

Strength

300 mg/1

NDC

71921010533

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209498

FDA Approved

3/2/2018

TE Code

AB

On Market Since

11/26/2025

Price Statistics

The NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has been published 39 times since Feb 25, 2026, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2814 per EA
All-time high$0.3314 (Apr 15, 2026)
All-time low$0.2814 (Nov 18, 2026)
52-week high$0.3314
52-week low$0.2814
Median price$0.3117
Average price$0.3113
Largest weekly change-5.9% (Apr 22, 2026)
Weeks tracked39
Tracking sinceFeb 25, 2026

Price History

1W

-4.8%

1M

-4.2%

3M

-9.5%

6M

-11.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, manufactured by Florida Pharmaceutical Products, LLC, is $0.2814 per EA (NDC 71921010533), effective Nov 18, 2026.

How has the price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has declined 11.7%. It has been tracked across 39 weekly CMS publications since Feb 25, 2026.

What are the highest and lowest recorded NADAC prices for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

Since Feb 25, 2026, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has ranged from a low of $0.2814 (Nov 18, 2026) to a high of $0.3314 (Apr 15, 2026), with a median of $0.3117 per EA.

Are there cheaper alternatives to TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (NDC 71921010533) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.